Megna v. Novartis Pharmaceutical Corporation & Associates | Search

Accessibility help Skip to navigation Skip to content Skip to footer

Showing results for Megna v. Novartis Pharmaceutical Corporation & Associates

Sort by

Viewing results 1‒6 of 6

FT Magazine
A controversial biotech and an unlikely anorexia treatment
...Psilocybin was first clinically manufactured in 1959 by Sandoz, now part of Novartis, but the company had never commercialised it....
March 2, 2023
FT and Schroders Business Book of the Year 2024
The Theranos tale exposes the dangers lurking in Silicon Valley
...The company had just completed its first big live demonstration for a pharmaceutical company....
November 14, 2018
FT Live
FT Women in Business Summit
Power and parity: Rewriting the rules for the future
Tuesday, 11 JuneLondon Marriott Hotel Grosvenor Square, Grosvenor Square, London, UK
Corporate culture
Legal profession must break its glass ceiling
...In the Fortune 500 — the largest US industrial corporations, listed by revenue — women make up only a quarter of general counsel....
March 8, 2018
Law
Top 10 innovative lawyers in North America
...She was appointed as the first cyber security counsel for a major corporation, at IBM....
December 6, 2016
Letter
UK government must reinforce its commitment to science
...It drives growth and attracts a wealth of global corporations, investors and charities....
September 7, 2015
beyondbricsMarkets
From silent majority to strategic challengers: China’s new stakeholders for MNCs
...In 2013, the Chinese government inspected most major global pharmaceuticals companies, such as Novartis, AstraZeneca, Sanofi, Bayer and GSK on the bribery issue, leading to many of them substantively revamping...
October 13, 2015
FT Live
Innovative Lawyers Awards Asia-Pacific
Celebrating innovations from both law firms and in-house teams in the region
Thursday, 16 MayHong Kong

Previous pagePage 1 of 1Next page